Gilead Sciences Inc (NASDAQ:GILD)
| 77.08 Delayed Data As of May 26 |  -0.57 / -0.73%Today’s Change | 57.17 Today|||52-Week Range 89.74 | -10.22% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Oday Daniel P Chairman & Chief Executive Officer |  Sale | 1/24/2023 | 59,078 | $84.02 | $5.0M | -8.25% |
Parsey Merdad V Chief Medical Officer | Sale | 1/24/2023 | 17,749 | $84.02 | $1.5M | -8.25% |
Wilfong Diane E Chief Accounting Officer & Senior Vice President | Sale | 11/01/2022 | 16,255 | $79.25 | $1.3M | -2.84% |
Dickinson Andrew D Chief Financial Officer | Sale | 1/24/2023 | 15,327 | $84.02 | $1.3M | -8.25% |
Mercier Johanna Chief Commercial Officer | Sale | 1/24/2023 | 15,325 | $84.02 | $1.3M | -8.25% |
Wilfong Diane E Chief Accounting Officer & Senior Vice President |  Buy | 11/01/2022 | 16,255 | $72.70 | $1.2M | -2.84% |
Oday Daniel P Chairman & Chief Executive Officer | Sale | 3/10/2023 | 14,017 | $79.50 | $1.1M | -3.03% |
Wilfong Diane E Chief Accounting Officer & Senior Vice President | Sale | 11/09/2022 | 6,416 | $83.50 | $535.7K | -6.35% |
Parsey Merdad V Chief Medical Officer | Sale | 3/13/2023 | 6,126 | $78.99 | $483.9K | -3.04% |
Lofton Kevin E Director | Buy | 3/09/2023 | 8,442 | $52.38 | $442.2K | -2.36% |
Page of 9